NHS Framework Agreement for the supply of Adult Influenza Vaccines – Secondary Care

A Contract Award Notice
by THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)

Source
Find a Tender
Type
Framework (Goods)
Duration
not specified
Value
4
Sector
HEALTH
Published
08 Sep 2021
Delivery
not specified
Deadline
n/a

Concepts

Location

United Kingdom: Please refer to Document 4d as issued with the ITO Documents for the list of purchasing points (Schedule 8 of Document 3 refers)

Geochart for 1 buyers and 4 suppliers

1 buyer

2 suppliers

Description

NHS Framework Agreement for the supply of Adult Influenza Vaccines – Secondary Care. Period of framework agreement: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months . Please refer to the invitation to offer documents for a list of the purchasing points.

Lot Division

1 aQIV
  • Value: 1

NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points
2 QIV-HD

NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods upto36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points
3 QIVc
  • Value: 1

NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods upto36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points
4 QIVr
  • Value: 1

NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods upto36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points
5 QIVe
  • Value: 1

NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points

Award Detail

1 Seqirus (Maidenhead)
  • aQIV
  • Reference: 022304-2021-cm/phs/20/5623-1
2 Seqirus (Maidenhead)
  • QIVc
  • Reference: 022304-2021-cm/phs/20/5623-2
3 Aventis Pharma (Reading)
  • QIVr
  • Reference: 022304-2021-cm/phs/20/5623-3
4 Aventis Pharma (Reading)
  • QIVe
  • Reference: 022304-2021-cm/phs/20/5623-4

Award Criteria

Security of Supply 10%
Ease of Use 3%
price 87%

CPV Codes

  • 33651660 - Influenza vaccines

Indicators

  • Options are available.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

Domains